Implications of capecitabine (Xeloda) for cancer nursing practice

European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society
Bonnie-Mae Gerbrecht, Tuija Kangas

Abstract

Home-based therapy with oral capecitabine (Xeloda) has a number of advantages over i.v. hospital-based chemotherapy regimens, including improvement in patients' quality of life, and medical resource/cost savings compared with 5-FU/LV in metastatic colorectal cancer. In addition, the ability of capecitabine to extend survival beyond docetaxel in patients with previously treated metastatic breast cancer means that capecitabine plus docetaxel is a very cost-effective combination. Oncology nurses should prepare for the increased use of oral capecitabine as a single agent or in combination regimens in the outpatient setting. The use of this drug requires enhanced patient education skills, communication (e.g. telephone contact) and patient management on the part of the nurse. Oncology nurses will also need to accept a more significant and pivotal role in the clinical oncology team, not only as a point of contact between the patient and clinician, but also in documenting the benefits of capecitabine to ensure the effective management of patients receiving the drug.

References

Jun 1, 1980·Annals of Internal Medicine·B R CassilethV March
Aug 10, 1999·Drugs·M Dooley, K L Goa
Mar 11, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K Sikora
Apr 6, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C TwelvesUNKNOWN Xeloda Colorectal Cancer Study Group
May 2, 2002·Journal of the National Cancer Institute·Ann H PartridgeEric P Winer
Jun 12, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J CassidyUNKNOWN Capecitabine Colorectal Cancer Study Group
Jun 18, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joyce O'ShaughnessyRobert Leonard
Nov 16, 2002·British Journal of Cancer·V J O'Neill, C J Twelves
Apr 8, 2003·Current Medicinal Chemistry. Anti-cancer Agents·Cristiano FerliniGiovanni Scambia
Oct 14, 2003·The Lancet Oncology·Jessica Corner
Jan 7, 2004·Clinical Journal of Oncology Nursing·Ann Birner
Sep 3, 2004·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Hilde MarséSonia Valverde
Sep 3, 2004·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Ian ChauPierre Fumoleau
Sep 3, 2004·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Sara Faithfull, Paula Deery

❮ Previous
Next ❯

Citations

Jun 8, 2006·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Sultan Kav, Humeyra Bostanci
Dec 17, 2008·Women's Health·Mariko Morishita, Robert C Leonard
Mar 14, 2007·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Joan D Webster-GandyKaren Harrold
Dec 26, 2006·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·A MacLeodL MacDonald
Aug 25, 2006·Clinical Journal of Oncology Nursing·Deborah T Berg
Dec 29, 2013·Oncology Nursing Forum·Janna C Roop, Horng-Shiuann Wu
Aug 12, 2016·Japanese Journal of Clinical Oncology·Naoko MikoshibaMitsunori Miyashita
Feb 11, 2015·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Naoko MikoshibaMitsunori Miyashita

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society
Hilde MarséSonia Valverde
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society
Sara Faithfull, Paula Deery
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society
Cora N SternbergMichelle Holland
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Chris TwelvesXeloda Colorectal Cancer Study Group
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society
Ian ChauPierre Fumoleau
© 2021 Meta ULC. All rights reserved